Letter to the Editor. A Response to: Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center

Katherine Clark, Jason W. Boland, David C. Currow

Research output: Contribution to journalLetterpeer-review

Abstract

To the Editor
We congratulate Walter et al for successfully completing a single arm, open-label trial of combination pharmacological therapy in the palliative management of inoperable bowel obstruction.1 In a challenging area to research, this work provides a platform for future projects.
Original languageEnglish
Pages (from-to)e919-e920
Number of pages2
JournalJournal of Pain and Symptom Management
Volume67
Issue number6
DOIs
Publication statusPublished - Jun 2024
Externally publishedYes

Keywords

  • Inoperable malignant bowel obstruction
  • pharmacological treatment
  • palliative management
  • metoclopramide
  • dexamethasone
  • octreotide

Fingerprint

Dive into the research topics of 'Letter to the Editor. A Response to: Palliative Management of Inoperable Malignant Bowel Obstruction: Prospective, Open Label, Phase 2 Study at an NCI Comprehensive Cancer Center'. Together they form a unique fingerprint.

Cite this